ASCIA News
-
ASCIA launches fresh design for website
7 August 2018: It is a pleasure to announce that the ASCIA website www.allergy.org.au has been redesigned to be more user and device friendly. The ASCIA website is a trusted and extremely popular source of information about allergy and other immune diseases. We have therefor... -
ASCIA Conference deadline extended to Monday 23 July 2018 for earlybird registration and abstract submission
To take advantage of the discounted earlybird registration rates for the ASCIA 2018 Conference you need to register by the extended deadline of Monday 23 July 2018. This is also the extended deadline for poster and clinical grand round abstract submissions. Please note that... -
ASCIA 2018 Conference registration is now open
Registration is now open at www.ascia2018.com for the ASCIA 2018 conference, the 29th annual conference of the Australasian Society of Clinical Immunology and Allergy (ASCIA). The ASCIA 2018 conference will run for 3 days, from Wednesday 5 to Friday 7 September 2018 at the N... -
EpiPen® supply update
17 May 2018: EpiPen® 300mcg adrenaline (epinephrine) autoinjectors continue to be distributed each week via wholesalers to pharmacies. Mylan has recently introduced an EpiPen toll-free hotline 1800 931 625 for inquiries about supply. If a pharmacy is out of stock the pharmac... -
How to remove ticks to prevent allergic reactions
8 May 2018: The ASCIA website article on tick allergy has been updated to highlight the following information on how to remove ticks to prevent allergic reactions. To prevent allergic reactions to ticks do NOT forcibly remove the tick. Disturbing the tick may cause the tick... -
Update on supply of venom immunotherapy products in Australia and New Zealand
5 May 2018: As previously communicated, events overseas have impacted the ability of Stallergenes Greer to supply venom immunotherapy products to Australia and New Zealand. Stallergenes Greer has now advised ASCIA of the following supply update. Honey Bee venom Hymenoptera H... -
Changes to Medicare-funded allergy testing - effective 1 November 2018
5 May 2018: The Australian Government is making changes to Medicare-funded dermatology, allergy and immunology services, following recommendations from the Medicare Benefits Schedule (MBS) Review Taskforce. New restrictions on allergen testing will be introduced on 1 Novembe... -
ASCIA website update – new documents about how to introduce solid foods for allergy prevention (FAQ) and oral immunotherapy (OIT) for food allergy
2 May 2018: The following two new ASCIA documents for parents, patients, carers and consumers are now available on the ASCIA website: How to introduce solid foods for allergy prevention - in a new frequently asked questions (FAQ) format Oral immunotherapy (OIT) for food alle...
About ASCIA
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases
Quick Links
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Accreditiation
This site complies with the HONcode standard for trustworthy health information.Verify here.